Definition of prepartum hyperketonemia in dairy goats.
A prospective cohort study was conducted on 1,081 dairy goats from 10 commercial herds in Québec (Canada) to define prepartum hyperketonemia based on optimal blood β-hydroxybutyrate acid threshold values for the early prediction of pregnancy toxemia (PT) and mortality in late-gestation dairy goats. All pregnant goats had blood sampled weekly during the last 5wk of pregnancy. The blood was analyzed directly on the farm for β-hydroxybutyrate acid quantification using a Precision Xtra meter (Abbott Diabetes Care, Saint-Laurent, QC, Canada). Body condition scores on the lumbar region and sternum were noted. Each goat was classified as being at low (n=973) or high risk (n=108) of having PT by producers based on a standardized definition. The optimal threshold for predicting a PT diagnosis or mortality for each week before kidding was determined based on the highest sum of sensitivity and specificity. The association between hyperketonemia and subsequent PT was tested using a multivariable logistic regression model considering hyperketonemia at wk 4 prepartum, litter size, and body condition score at wk 4 prepartum as covariates, and herd and parturition cohort as random effects. The association between mortality and hyperketonemia was also tested using a logistic regression model accounting for the presence or absence of treatment during the last month of pregnancy. The hyperketonemia definition based on PT varied between ≥0.4 and ≥0.9mmol/L during the last 5wk prepartum. Goats affected by hyperketonemia at wk 4 prepartum and with a large litter size (≥3 fetuses) had 2.1 and 40.5 times the odds, respectively, of subsequent PT than other goats. Hyperketonemia definitions based on mortality varied between ≥0.6 and ≥1.4mmol/L during the last 4wk prepartum, and was ≥1.7mmol/L during the first week postpartum. Goats affected by hyperketonemia and treated by producers had 3.4 and 11.8 times the odds, respectively, of subsequent mortality than did other goats. These results showed that prepartum hyperketonemia could be defined in dairy goats using subsequent risks of PT or mortality during the last month of pregnancy.
Département de Sciences Cliniques, Faculté de Médecine Vétérinaire, C.P. 5000, Université de Montréal, Saint-Hyacinthe, Québec, J2S 7C6, Canada.
V
V
Doré
Département de Sciences Cliniques, Faculté de Médecine Vétérinaire, C.P. 5000, Université de Montréal, Saint-Hyacinthe, Québec, J2S 7C6, Canada.
J
J
Dubuc
Département de Sciences Cliniques, Faculté de Médecine Vétérinaire, C.P. 5000, Université de Montréal, Saint-Hyacinthe, Québec, J2S 7C6, Canada.
A M
AM
Bélanger
Département de Sciences Cliniques, Faculté de Médecine Vétérinaire, C.P. 5000, Université de Montréal, Saint-Hyacinthe, Québec, J2S 7C6, Canada. Electronic address: s.buczinski@umontreal.ca.
S
S
Buczinski
D020155:3-Hydroxybutyric Acid / Q000097:blood; D000818:Animals; D002170:Canada; D002417:Cattle; D015331:Cohort Studies; D005260:Female; D015511:Goat Diseases / Q000097:blood* / Q000401:mortality; D006041:Goats / Q000097:blood; D007662:Ketosis / Q000097:blood / Q000628:therapy / Q000662:veterinary*; D016015:Logistic Models; D049590:Postpartum Period; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000662:veterinary*; D011446:Prospective Studies; D011792:Quebec; D012307:Risk Factors; D012680:Sensitivity and Specificity; D014115:Toxemia / Q000453:epidemiology / Q000662:veterinary
D020155:3-Hydroxybutyric Acid
dairy goat; hyperketonemia; pregnancy toxemia; β-hydroxybutyric acid